# Efficacy of Esketamine for Patients With Irritable Bowel Syndrome

> **NCT06788444** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 552 (estimated)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **PROCEDURE:** The colonoscopy
- **DRUG:** Esketamine

## Key facts

- **NCT ID:** NCT06788444
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-18
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 552 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06788444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06788444, "Efficacy of Esketamine for Patients With Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06788444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*